Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 353.60
Bid: 354.80
Ask: 355.40
Change: 5.60 (1.61%)
Spread: 0.60 (0.169%)
Open: 350.20
High: 356.60
Low: 348.80
Prev. Close: 348.00
QQ. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Second Quarter Trading Update

11 Oct 2023 07:00

RNS Number : 6985P
QinetiQ Group plc
11 October 2023

News release

QinetiQ Group plc

Second Quarter Trading Update

11 October 2023 - QinetiQ Group plc ("QinetiQ" or "the Group") today issues a trading update covering its second quarter of trading.

Strong organic first half performance - on track to deliver full year expectations

The Group has delivered a strong second quarter, resulting in improved organic revenue growth and operating profit margin in the first half of the year compared to the same period last year. We also secured a record first half order intake at c.£950m, increasing our order backlog and improving our revenue under contract for the full year to 90%, consistent with the prior year. Whilst cash conversion in the first half was lower than the prior year due to short-term timing, full year cash conversion will be in line with our previous guidance. With significant new orders and major contract renewals, we have de-risked the second half and are on track to deliver another year of good organic revenue growth at stable margins in-line with our full year expectations and long-term guidance.

Global Solutions has performed well. The former Avantus business in the US continues to deliver revenue at double-digit margin and had an excellent second quarter securing a number of new programmes and significant contract renewals. Major examples are the five-year $224m contract to provide mission support to the US Space Development Agency (SDA) and the recently announced five-year $127m contract with the US Department of Defence (DoD) Strategic Capabilities Office (SCO). Winning these strategic contracts, coupled with significant progress on integration, builds momentum to deliver double-digit revenue growth at stable margins. The combination of the capabilities across the former Avantus business and QinetiQ has created a strong growth platform, demonstrated by securing c.$600m of multi-year contract awards[1] in the US during the first half of the year.

EMEA Services has also continued to perform well. We have delivered impressive organic revenue growth with improved profit margin, and secured orders of more than £600m. In the UK, the Long Term Partnering Agreement (LTPA), Engineering Delivery Partner (EDP) and Maritime Strategic Capability Agreement (MSCA) contracts continue to deliver for our customers' critical missions, supporting our strong operational performance. In Australia, the business is progressing well with the integration of Air Affairs and seeing initial demand for our new Engineering facility in Melbourne, where we are establishing sovereign capability to deliver specialist command and control vehicles.

Steve Wadey, Group Chief Executive Officer said:

"I am extremely pleased that the Group continues to perform well, delivering strong organic revenue growth at stable margins in the first half of the year, moderately ahead of expectations. Record first half order intake demonstrates that our distinctive offerings remain in high demand across all our home countries, as our people continue to deliver high-value services and products critical to national defence and security. Based on our strong first half performance, we have de-risked our full year results and are on track to deliver another year of good organic revenue growth at stable margins in line with our full year expectations.

"Our strong operational performance combined with disciplined execution of our multi-domestic strategy demonstrates our robust financial framework in action, delivering attractive value and long-term sustainable success for our shareholders."

Investor Seminar: Key drivers of our global growth

QinetiQ will host an Investor Seminar on 25 October 2023 in New York, covering three of the key growth drivers for the company: our UK Intelligence business, Avantus and our wider US business, and our global threat representation capabilities. You are warmly invited to join in person or via live webcast.

To register to attend: https://www.qinetiq.com/en/investors/investor-seminars/key-drivers-of-our-global-growth

FY24 Interim Results

QinetiQ will publish its full Interim Results on Thursday 16 November 2023. We will be hosting an in-person results presentation at 09:30 GMT at the London Stock Exchange, 10 Paternoster Square, London, EC4M 7LS. Registration to join in-person or via the live webcast will be available after the Investor Seminar.

About QinetiQ

QinetiQ is an integrated global defence and security company focused on mission-led innovation. QinetiQ employs more than 8,500 highly-skilled people, committed to creating new ways of protecting what matters most; testing technologies, systems, and processes to make sure they meet operational needs; and enabling customers to deploy new and enhanced capabilities with the assurance they will deliver the performance required. Visit our website www.QinetiQ.com. Follow us on LinkedIn and Twitter @QinetiQ. Visit our blog www.QinetiQ-blogs.com.

For further information please contact:

John Haworth, Group Director Investor Relations:

+44 (0) 7920 545841

Lindsay Walls, Group Director Communications (Media enquiries):

+44 (0) 7793 427582


[1] Of which $169m orders recognised in our total US first half order intake of $357m

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
TSTBRBDGXUBDGXG
Date   Source Headline
3rd May 20247:00 amRNSTransaction in Own Shares
2nd May 20247:00 amRNSTransaction in Own Shares
30th Apr 20244:00 pmRNSTotal Voting Rights
30th Apr 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:01 amRNSDirectorate Change, Leadership Team appointments
16th Apr 20247:00 amRNSQinetiQ Group plc Fourth Quarter Trading Update
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20244:35 pmRNSDirector/PDMR Shareholding
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20247:00 amRNSTotal Voting Rights
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSDirectorate Change
18th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20245:24 pmRNSHolding(s) in Company
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20244:05 pmRNSHolding(s) in Company
13th Mar 20244:00 pmRNSHolding(s) in Company
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20245:21 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20241:54 pmRNSDirector Declaration
5th Mar 202412:08 pmRNSDirector Declaration
5th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20247:00 amRNSTransaction in Own Shares
29th Feb 20244:00 pmRNSTotal Voting Rights
29th Feb 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.